Viva Biotech hosts drug discovery webinar

On May 20, 2026, Cabio Biotech hosted a V-Experts in Conversation webinar titled 'Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry'. Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. BingX and Dr. Timothy Dwight IV. The discussion focused on how integrated screening workflows with medicinal chemistry streamline decisions in early drug discovery, from hit identification to lead optimization. Dr. BingX emphasized the target-dependent nature of hit identification and Cabio Biotech's V-DEL approach for early target assessment. Dr. Timothy Dwight IV highlighted the importance of design-make-test-analyze cycles and close coordination across various teams in medicinal chemistry. The webinar reinforced that integration of data, expertise, and decision points is crucial for a continuous and efficient discovery workflow.